Accounting standard newly cited
Filing comparison
Universe Pharmaceuticals INC cited accounting standard ASU 2016-13 for the first time in this filing series
The filing states this standard was adopted in 2022, so this is the first time it has been cited in this series rather than a change of policy in the current period.
Effective October 1, 2022, the Company adopted Accounting Standards Update (“ASU”) No.2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using the modified retrospective transition method.
Evidence
- Adopted
- 2016-13
- Adoption year stated
- 2022
- Caveat
- The filing states this standard was adopted in 2022, so this is the first time it has been cited in this series rather than a change of policy in the current period.
- Contexts
- Effective October 1, 2022, the Company adopted Accounting Standards Update (“ASU”) No.2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using the modified retrospective transition method.
- New standards
- 2016-13, 2025-05, 2025-08, 2025-10
- Prior filed
- 2025-04-29
- Prior form
- 20-F
- Restates existing policy
- Yes
- Source
- accounting standards update (ASU) reference comparison
- Why
- An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.